Kim MY - Search Results

1

Systematic identification of a synthetic lethal interaction in brain-metastatic lung adenocarcinoma.

Moon JW, Hong BJ, Kim SK, Park MS, Lee H, Lee J, Kim MY. Moon JW, et al. Among authors: kim sk, kim my. Cancer Lett. 2024 Apr 28;588:216781. doi: 10.1016/j.canlet.2024.216781. Epub 2024 Mar 15. Cancer Lett. 2024. PMID: 38494150

2

Oncogenic KRAS Sensitizes Lung Adenocarcinoma to GSK-J4-Induced Metabolic and Oxidative Stress.

Hong BJ, Park WY, Kim HR, Moon JW, Lee HY, Park JH, Kim SK, Oh Y, Roe JS, Kim MY. Hong BJ, et al. Among authors: kim sk, kim hr, kim my. Cancer Res. 2019 Nov 15;79(22):5849-5859. doi: 10.1158/0008-5472.CAN-18-3511. Epub 2019 Sep 10. Cancer Res. 2019. PMID: 31506334

3

H3K27 Demethylase JMJD3 Employs the NF-κB and BMP Signaling Pathways to Modulate the Tumor Microenvironment and Promote Melanoma Progression and Metastasis.

Park WY, Hong BJ, Lee J, Choi C, Kim MY. Park WY, et al. Among authors: kim my. Cancer Res. 2016 Jan 1;76(1):161-70. doi: 10.1158/0008-5472.CAN-15-0536. Cancer Res. 2016. PMID: 26729791

4

GALNT3 suppresses lung cancer by inhibiting myeloid-derived suppressor cell infiltration and angiogenesis in a TNFR and c-MET pathway-dependent manner.

Park MS, Yang AY, Lee JE, Kim SK, Roe JS, Park MS, Oh MJ, An HJ, Kim MY. Park MS, et al. Among authors: kim sk, kim my. Cancer Lett. 2021 Aug 17;521:294-307. doi: 10.1016/j.canlet.2021.08.015. Online ahead of print. Cancer Lett. 2021. PMID: 34416337

5

PARP1 and PRC2 double deficiency promotes BRCA-proficient breast cancer growth by modification of the tumor microenvironment.

Yang AY, Choi EB, So Park M, Kim SK, Park MS, Kim MY. Yang AY, et al. Among authors: kim sk, kim my. FEBS J. 2021 May;288(9):2888-2910. doi: 10.1111/febs.15636. Epub 2020 Dec 2. FEBS J. 2021. PMID: 33205541 Free article.

6

A TEAD2-Driven Endothelial-Like Program Shapes Basal-Like Differentiation and Metastasis of Pancreatic Cancer.

Yoo HB, Moon JW, Kim HR, Lee HS, Miyabayashi K, Park CH, Ge S, Zhang A, Tae YK, Sub Y, Park HW, Gee HY, Notta F, Tuveson DA, Bang S, Kim MY, Roe JS. Yoo HB, et al. Among authors: kim hr, kim my. Gastroenterology. 2023 Jul;165(1):133-148.e17. doi: 10.1053/j.gastro.2023.02.049. Epub 2023 Mar 11. Gastroenterology. 2023. PMID: 36907523 Free PMC article.

7

ANKRD9 is associated with tumor suppression as a substrate receptor subunit of ubiquitin ligase.

Lee Y, Lim B, Lee SW, Lee WR, Kim YI, Kim M, Ju H, Kim MY, Kang SJ, Song JJ, Lee JE, Kang C. Lee Y, et al. Among authors: kim yi, kim m, kim my. Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3145-3153. doi: 10.1016/j.bbadis.2018.07.001. Epub 2018 Jul 3. Biochim Biophys Acta Mol Basis Dis. 2018. PMID: 30293565 Free article.

8

c-MYC Drives Breast Cancer Metastasis to the Brain, but Promotes Synthetic Lethality with TRAIL.

Lee HY, Cha J, Kim SK, Park JH, Song KH, Kim P, Kim MY. Lee HY, et al. Among authors: kim sk, kim p, kim my. Mol Cancer Res. 2019 Feb;17(2):544-554. doi: 10.1158/1541-7786.MCR-18-0630. Epub 2018 Sep 28. Mol Cancer Res. 2019. PMID: 30266755

9

Cancer epigenetics: Past, present and future.

Lee JE, Kim MY. Lee JE, et al. Among authors: kim my. Semin Cancer Biol. 2022 Aug;83:4-14. doi: 10.1016/j.semcancer.2021.03.025. Epub 2021 Mar 31. Semin Cancer Biol. 2022. PMID: 33798724 Review.

10

GALNT14 promotes lung-specific breast cancer metastasis by modulating self-renewal and interaction with the lung microenvironment.

Song KH, Park MS, Nandu TS, Gadad S, Kim SC, Kim MY. Song KH, et al. Among authors: kim sc, kim my. Nat Commun. 2016 Dec 16;7:13796. doi: 10.1038/ncomms13796. Nat Commun. 2016. PMID: 27982029 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,203 results

Search Page